[Guidelines for the treatment of non-neurological urinary incontinence in women using periurethral balloons].
A new minimally invasive technique using an adjustable implantable material has recently been developed: adjustable periurethral balloons. Initially designed by Uromedica, Inc., Plymouth, MN, USA, they are currently marketed in France by Medtronic (Minneapolis, MN, USA), called ACT (Adjustable Continence Therapy). Given the data reported in the literature today, ACT devices in women should only be a last-resort technique. They can only be implanted in patients presenting urinary incontinence due to sphincter deficiency with no urethral hypermobility (negative support maneuvers), in cases of failure of other therapies, or when placing an AUS is contraindicated or refused by the patient (French National Health Authority).